Fresh2 Group Ltd - FRES Net earnings per share for the last four quarters

Fresh2 Group Limited (FRES) relies on external cloud servers and partner logistics in China. The relative EPS YoY TTM growth rate demonstrates current profitability, with the actual value equal to . Despite its status as a promising brand in oncology risk diagnostics, a lack of pricing power and micro-capitalization leave the business vulnerable to market dumping.

Fresh2 Group Limited (FRES) maintains sustainable barriers to entry for competitors through its complex IT infrastructure and stringent medical equipment certification. This 12-month YoY change in net income per share quantifies the efficiency of this monopoly by comparing the rolling EPS total. The upward trend confirms the scalability of the business model, while stagnation signals regulatory pressure. Analyzing this price action allows for the filtering of overheated local peaks, which is critical for assessing the asset's real value.